NO20033773L - Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet - Google Patents

Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet

Info

Publication number
NO20033773L
NO20033773L NO20033773A NO20033773A NO20033773L NO 20033773 L NO20033773 L NO 20033773L NO 20033773 A NO20033773 A NO 20033773A NO 20033773 A NO20033773 A NO 20033773A NO 20033773 L NO20033773 L NO 20033773L
Authority
NO
Norway
Prior art keywords
fungal
antibacterial
tumor activity
polyamide derivatives
polyamide
Prior art date
Application number
NO20033773A
Other languages
English (en)
Other versions
NO20033773D0 (no
Inventor
Natalia B Dyatkina
Dong-Fang Shi
Christopher Don Roberts
Mark Douglas Velligan
Sebastian Johannes Reinh Liehr
Janos Botyanszki
Wentao Zhang
Alexander Khorlin
Peter Harold Nelson
Joseph Martin Muchowski
Original Assignee
Genelabs Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Technology Inc filed Critical Genelabs Technology Inc
Publication of NO20033773D0 publication Critical patent/NO20033773D0/no
Publication of NO20033773L publication Critical patent/NO20033773L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20033773A 2001-12-26 2003-08-25 Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet NO20033773L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34379601P 2001-12-26 2001-12-26
US34382901P 2001-12-26 2001-12-26
PCT/US2002/041087 WO2003057212A1 (en) 2001-12-26 2002-12-24 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity

Publications (2)

Publication Number Publication Date
NO20033773D0 NO20033773D0 (no) 2003-08-25
NO20033773L true NO20033773L (no) 2003-10-23

Family

ID=26993629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033773A NO20033773L (no) 2001-12-26 2003-08-25 Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet

Country Status (6)

Country Link
US (1) US7064218B2 (no)
AU (1) AU2002364209A1 (no)
BR (1) BR0207583A (no)
NO (1) NO20033773L (no)
TW (1) TW200306815A (no)
WO (1) WO2003057212A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20010633A1 (it) * 2001-07-02 2003-01-02 Univ Ferrara Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a.
DE602004016992D1 (de) * 2003-05-02 2008-11-20 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3-carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
US20070123531A1 (en) * 2003-05-02 2007-05-31 Elan Pharmaceuticals, Inc. 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
JP4629037B2 (ja) * 2003-05-02 2011-02-09 エラン ファーマシューティカルズ，インコーポレイテッド 炎症疾患治療のためのブラジキニンｂ１受容体アンタゴニストとしての４−ブロモ−５−（２−クロロ−ベンゾイルアミノ）−１ｈ−ピラゾール−３−カルボン酸（１−（アミノカルボニル）エト−１−イル）アミド誘導体および関連化合物
US9512125B2 (en) 2004-11-19 2016-12-06 The Regents Of The University Of California Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
US20080032960A1 (en) 2006-04-04 2008-02-07 Regents Of The University Of California PI3 kinase antagonists
WO2009046448A1 (en) 2007-10-04 2009-04-09 Intellikine, Inc. Chemical entities and therapeutic uses thereof
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
NZ613219A (en) 2008-01-04 2014-11-28 Intellikine Llc Heterocyclic containing entities, compositions and methods
WO2009114874A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Benzothiazole kinase inhibitors and methods of use
JP5547099B2 (ja) * 2008-03-14 2014-07-09 インテリカイン， エルエルシー キナーゼ阻害剤および使用方法
CN102124009B (zh) 2008-07-08 2014-07-23 因特利凯公司 激酶抑制剂及其使用方法
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
US8273900B2 (en) 2008-08-07 2012-09-25 Novartis Ag Organic compounds
WO2010036380A1 (en) 2008-09-26 2010-04-01 Intellikine, Inc. Heterocyclic kinase inhibitors
AU2009305669A1 (en) 2008-10-16 2010-04-22 The Regents Of The University Of California Fused ring heteroaryl kinase inhibitors
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
EP2427195B1 (en) 2009-05-07 2019-05-01 Intellikine, LLC Heterocyclic compounds and uses thereof
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
CA2778357A1 (en) * 2009-10-22 2011-04-28 Polymedix, Inc. Processes for preparing a polymeric compound
UY32940A (es) * 2009-10-27 2011-05-31 Bayer Cropscience Ag Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
ES2593256T3 (es) 2010-05-21 2016-12-07 Infinity Pharmaceuticals, Inc. Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
CA2817577A1 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
UA115767C2 (uk) 2011-01-10 2017-12-26 Інфініті Фармасьютікалз, Інк. Способи отримання ізохінолінонів і тверді форми ізохінолінонів
CN106619647A (zh) 2011-02-23 2017-05-10 因特利凯有限责任公司 激酶抑制剂的组合及其用途
US9056877B2 (en) 2011-07-19 2015-06-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8969363B2 (en) 2011-07-19 2015-03-03 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
PE20141371A1 (es) 2011-08-29 2014-10-13 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos
EP2751112B1 (en) 2011-09-02 2019-10-09 The Regents of The University of California Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
EP2602248A1 (en) 2011-12-05 2013-06-12 University Of Leicester Novel pyrrole compounds
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8921426B2 (en) 2012-04-18 2014-12-30 International Business Machines Corporation Cationic bis-urea compounds as effective antimicrobial agents
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
JP2015532287A (ja) 2012-09-26 2015-11-09 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ｉｒｅ１の調節
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
GB201309932D0 (en) * 2013-06-04 2013-07-17 Univ Leicester Novel pyrrole derivative
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EA201690713A1 (ru) 2013-10-04 2016-08-31 Инфинити Фармасьютикалз, Инк. Гетероциклические соединения и их применения
DK3119397T3 (da) 2014-03-19 2022-03-28 Infinity Pharmaceuticals Inc Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
AU2016322552B2 (en) 2015-09-14 2021-03-25 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR20190033526A (ko) 2016-06-24 2019-03-29 인피니티 파마슈티칼스, 인코포레이티드 병용 요법
CN106832175B (zh) * 2017-02-17 2019-10-18 华南理工大学 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用
CN111641046B (zh) * 2020-05-07 2021-07-06 宁波大学 一种微波段宽带圆二色性手性吸波器

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
CA1308516C (en) 1987-07-06 1992-10-06 J. William Lown Oligopeptide anticancer and antiviral agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
EP0679088B1 (en) * 1992-09-29 2002-07-10 Inhale Therapeutic Systems Pulmonary delivery of active fragments of parathyroid hormone
AU7380294A (en) 1993-08-06 1995-02-28 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
US5770736A (en) * 1994-06-21 1998-06-23 Northeastern University Reagents for cleavage or crosslinking of biomolecules using nondiffusible reactive intermediates
US5502068A (en) 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
JP4061819B2 (ja) * 2000-05-12 2008-03-19 独立行政法人科学技術振興機構 インターストランドクロスリンク剤の合成方法
WO2002000650A2 (en) * 2000-06-27 2002-01-03 Genelabs Technologies, Inc. Novel compounds possessing antibacterial, antifungal or antitumor activity

Also Published As

Publication number Publication date
NO20033773D0 (no) 2003-08-25
BR0207583A (pt) 2004-04-27
WO2003057212A1 (en) 2003-07-17
US7064218B2 (en) 2006-06-20
AU2002364209A1 (en) 2003-07-24
TW200306815A (en) 2003-12-01
US20030212113A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
NO20033773L (no) Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet
FR15C0068I2 (fr) Derives de diamine
DE60202270D1 (de) 4,5-dihydro-1h-pyrazolderivate mit cb1-antagonistischer wirkung
NO20014128D0 (no) Camptothecinderivater som har antitumoraktivitet
NO20041176L (no) Nye 4,5-dihydro- 1H-pyrazolderivater med CB1-antagonistisk aktivitet
NO20025720L (no) Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet
NO20035634L (no) Diamin-derivater
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
ITTO20010940A0 (it) ,,sedia,,
DK1281310T3 (da) Höstmaskine med hastighedsstyring
PT1406628E (pt) Derivados de tera-hidroquinolina
DE50213548D1 (de) Substituierte 2-carba-3,5-dicyano-4-aryl-6-aminopylektive liganden
DK1423071T3 (da) Absorberende artikel, der har åbninger i det absorberende legeme
BR0201919B1 (pt) colheitadeira.
ATE397610T1 (de) Avermectinmonosaccharidderivate mit pestiziden eigenschaften
DK1373290T3 (da) Pesticidale spinosynderivater
DE60317234D1 (de) Dihalo-allyloxy-phenol-derivate mit pestizid-aktivität
DE60117900D1 (de) Phytosphingosinderivate mit Antitumorwirkung
FR2834289B1 (fr) Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques
DE50309025D1 (de) Inhärent vernetzbare polyamide
FR2823089B1 (fr) Cintre coulissant extensible
ES1050769Y (es) Galleta perfeccionada.
DK1373216T3 (da) 4,5-dihydro-1H-pyrazolderivater med CB1-antagonistisk aktivitet
ES1048424Y (es) Colgador perfeccionado.
ES1054003Y (es) Pantalon perfeccionado.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application